Science

A locally developed cervical cancer vaccine will be rolled out in two months

The Department of Biotechnology (DBT) has announced the scientific completion of India’s first locally developed cervical cancer vaccine. The quadrivalent human papillomavirus (qHPV) vaccine (types 6, 11, 16 and 18) protects against cervical cancer and genital warts.

HPV vaccine

The HPV vaccine, which should be rolled out in a few months, was developed by Serum Institute of India, and Serum Institute Managing Director Adar Poonawalla said the price could be between ₹200 and ₹400, although the price has yet to be finalized. The vaccine received marketing clearance from the Drug Controller General of India (DCGI) in the second week of July.

The development of the vaccine was supported by the DBT under its Grand Challenges India initiative and implemented by the Biotechnology Industry Research Assistance Council (BIRAC).

HPV infection

Cervical cancer is one of the leading causes of cancer death among women worldwide and disproportionately affects women, mainly in low- and middle-income (LMIC) countries, according to an official note on development. “Four-fifths of the nearly 2,75,000 annual cervical cancer deaths occur in LMICs where routine gynecological screening is minimal or absent,” he added.

HPV infection is responsible for more than 95% of cervical cancers worldwide. And cervical cancer is the second most common cancer among women in India, despite being largely preventable.

ALSO READ: Why Some Women Are More Likely To Get Cervical Cancer

Dosages and affordable price

The vaccine will be in two doses for 9-14 year olds and in three doses for 15-26 year olds. The Indian vaccine should be available at an affordable cost, according to the DBT note.

DBT has provided support for various vaccine innovations in the country, working towards an enabling environment for greater vaccine science and research. Dr. Rajesh S Gokhale, Secretary of DBT and President of BIRAC, said in a statement that it is “a much-needed affordable, low-cost quadrivalent HPV vaccine that will help prevent cervical cancer deaths. of the womb in India and around the world”.

Published on

September 01, 2022

Related Article

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button